Appetite Control

5-HTP is the direct serotonin precursor that crosses the blood–brain barrier, increasing central serotonin levels and suppressing appetite. Multiple double-blind RCTs confirm reduced caloric intake (by ~421 kcal/day in one study) and weight loss at 600–900 mg/day. Examine.com rates its appetite evidence Grade A from 8 trials and 711 participants.

A randomized, double-blind crossover trial (n=48) published in Nutrients (2021) found that 40 g of acacia gum significantly reduced hunger and increased fullness at 15 and 240 minutes post-meal. A separate metabolic syndrome RCT (n=61, 20 g/day, 12 weeks) also reported a decreased appetite score after gum arabic consumption. The effect is attributed to acacia's soluble fiber slowing gastric emptying.

Adzuki bean's high fiber and protein content promotes satiety by slowing gastric emptying and extending the feeling of fullness. Animal studies suggest the bean modulates hypothalamic neuropeptides governing appetite. The combination of low caloric density with high nutrient density supports appetite regulation.

Agar is a soluble, gel-forming fiber that swells in the stomach, promoting satiety and potentially reducing caloric intake. The landmark Maeda et al. (2005) RCT found greater calorie reduction — particularly at the evening meal — in the agar diet group, suggesting appetite suppression. A separate RCT found agar jelly delayed gastric emptying compared to a matched liquid control, a mechanism associated with prolonged fullness.

A. muciniphila stimulates GLP-1 and PYY secretion from gut enteroendocrine cells, hormones that suppress appetite and promote satiety. The secreted protein P9 and propionate both independently trigger GLP-1 release from intestinal L-cells. While direct human appetite endpoint trials are lacking, the GLP-1 mechanism is well-established, and body weight and fat mass showed favorable trends in the 2019 human RCT.

Alginate forms a viscous gel in the stomach that can promote satiety and reduce energy intake in acute settings. Several human trials show reduced postprandial hunger ratings, though long-term effects on appetite are inconsistent. A 2013 systematic review concluded most human studies support some suppression of satiety and energy intake depending on formulation.

Multiple RCTs demonstrate that almonds consumed as snacks promote satiety and reduce subsequent meal energy intake in a dose-dependent manner. Almonds also suppress implicit wanting of high-fat foods and produce a higher satiety quotient compared to carbohydrate-matched snacks. These effects are attributed to their protein, fiber, and fat content.

Apple fiber, particularly pectin, has been shown in human studies to promote satiety and reduce subsequent food intake. The high water and fiber content of whole apples contributes to gastric distension and slowed gastric emptying. RCTs and observational studies support a role for whole apples in reducing hunger between meals.

Short-term human studies suggest ACV may modestly reduce appetite and promote satiety, likely by slowing gastric emptying. A 2022 literature review found 4 of 6 short-term studies showed appetite suppression, but none of the long-term studies replicated this. Effects are inconsistent and depend on acetic acid concentration.

Atractylodes (as atractylenolide-I) has been studied in a randomized pilot trial for appetite improvement in cancer cachexia patients. Traditionally, it is one of the primary TCM indications for the herb. Preclinical work suggests it may stimulate gastric motility and digestive enzyme activity.

A small crossover clinical trial (Garvey et al., Nutrition & Health, 2017; n=20) found that consuming a smoothie containing 15 g of baobab extract significantly reduced subjective feelings of hunger compared with a matched placebo drink. However, a separate study using baobab extract found no significant difference in self-reported hunger or subsequent ad libitum energy intake, suggesting the appetite-suppressing effect may be modest and context-dependent. Baobab's high soluble fiber content provides a plausible mechanism via gastric distension and delayed gastric emptying.

Barley β-glucan delays gastric emptying, increases meal viscosity, and promotes satiety hormones including PYY and GLP-1. Multiple RCTs document reduced subjective hunger and increased fullness following barley β-glucan consumption, with reductions in subsequent energy intake.

Beef protein has been studied specifically for its 'protein leverage' effects on energy intake in humans. Higher dietary protein, including beef as a source, is associated with increased satiety and reduced ad libitum energy intake.

Berberine modulates appetite-related hormones—reducing fasting ghrelin and elevating GLP-1—and activates AMPK, which collectively suppress food intake signals. Clinical trials show significant reductions in body weight, BMI, and waist circumference. Direct measurement of subjective hunger remains an acknowledged research gap; effects on body composition are better documented than appetite per se.

Soluble oat beta-glucan forms a viscous gel in the gastrointestinal tract that slows gastric emptying and nutrient absorption, blunting post-meal hunger signals. Clinical studies show beta-glucan increases subjective satiety, though effects on ad libitum food intake are inconsistent across trials. High molecular weight formulations at ≥4 g/meal appear most effective.

Bile acids modulate appetite indirectly through TGR5-mediated stimulation of GLP-1 and PYY from intestinal L-cells, both of which are established satiety signals that reduce food intake. Bariatric surgery-induced increases in bile acid concentrations are associated with elevated GLP-1 and PYY, contributing to reduced appetite. The bile acid–TGR5–GLP-1/PYY axis is a recognized mechanistic pathway linking bile salt physiology to appetite regulation.

A small human study found that a beverage containing black pepper reduced appetite compared to plain water. Piperine may also modulate appetite indirectly through thermogenic and metabolic effects. Traditional Ayurvedic medicine uses black pepper specifically to stimulate low appetite.

Alginic acid in bladderwrack forms a gel in the stomach that activates stretch receptors, prolonging satiety. Human studies on alginate supplements have shown reduced hunger and increased fullness after meals. These effects are attributable to the alginate component rather than the whole herb.

Dietary protein generally promotes satiety via GLP-1, PYY, and CCK signaling, and a PMC-published pilot RCT on rice germ supplementation in postmenopausal women showed significantly greater satiety scores in the supplemented group vs. placebo. As a protein source, brown rice protein can contribute to appetite regulation, though direct studies on the isolated protein powder and hunger/satiety endpoints are limited.

Butyrate indirectly modulates appetite through stimulation of GLP-1 and PYY from gut L-cells, which signal satiety. Human evidence links circulating butyrate levels to GLP-1 concentrations, and sodium butyrate supplementation has been shown to raise plasma GLP-1.

Caffeine transiently suppresses appetite and increases thermogenesis via adenosine receptor antagonism and sympathetic nervous system activation. Clinical evidence shows weak to moderate appetite effects as a standalone, with more consistent outcomes in combination with green tea catechins. A systematic review confirmed caffeine enhances thermogenesis, fat oxidation, and appetite suppression.

MCT intake (including C8) reduces subsequent ad libitum energy intake compared to long-chain fats in controlled trials, suggesting an effect on satiety. However, caprylic acid also acylates ghrelin, the hunger-stimulating hormone, creating a mechanistic tension. Net effect on appetite in human trials favors mild suppression when MCTs replace LCTs.

Capsaicin activates TRPV1 receptors in the GI tract and sensory nerves, triggering catecholamine release, stimulating GLP-1 and CCK, and suppressing ghrelin. Multiple RCTs demonstrate it reduces energy intake by approximately 74 kcal/meal and decreases appetite scores. A systematic review confirms consistent appetite-reduction effects across clinical studies at doses of 2–10 mg/day.

Multiple RCTs and systematic reviews demonstrate capsaicinoids reduce ad libitum energy intake and increase satiety signals. A 2012 systematic review found regular consumption significantly reduced appetite and energy intake. Effects are modest and partly mediated via TRPV1 activation and thermogenesis rather than satiety hormones alone.

Capsicum contains capsaicin and related capsaicinoids that activate TRPV1 receptors, increase thermogenesis, stimulate satiety peptides (GLP-1, CCK), and suppress ghrelin, reducing energy intake by approximately 74 kcal/meal in a systematic review. Capsicum is listed among herbal plants with appetite-suppressing properties in multiple systematic reviews. Traditional use in global cuisines for metabolism and appetite management spans millennia.

As a high-quality, slowly digested protein, casein contributes to satiety and appetite suppression, though some evidence suggests whey may produce greater acute satiety signaling. Multiple controlled trials and a PMC review found that casein and whey protein produce broadly similar reductions in appetite at matched doses, particularly above a protein threshold of ~25% of energy intake. Casein is recognized as contributing to greater fullness versus carbohydrates.

Multiple human trials show capsaicin, the active compound in cayenne pepper, reduces energy intake and suppresses appetite, partly by lowering ghrelin and altering sensory desire for fatty and sweet foods. Effects are dose-dependent but modest. A PMC-published systematic review (2017) confirmed appetite suppression is most evident with oral versus gastrointestinal-only delivery.

Chia seeds form a viscous mucilaginous gel when hydrated, which physically slows gastric emptying and blunts postprandial glucose excursions. Clinical trials show modest effects on satiety-related hormones, though subjective hunger ratings are inconsistently improved. Protein content (~5 g/oz) also contributes to satiety signaling.

Clinical trials demonstrate that chickpea consumption increases subjective satiety and reduces energy intake at subsequent meals compared to wheat-based or potato controls. The high protein and resistant starch content slows gastric emptying and blunts post-meal hunger signals. Controlled crossover studies in healthy adults document these effects across multiple chickpea forms.

Chicory inulin-type fructans (ITFs) modulate gut satiety hormones and reduce subjective hunger. Fermentation of inulin by colonic bacteria produces short-chain fatty acids (SCFAs) that stimulate GLP-1 and PYY secretion from enteroendocrine cells. Multiple RCTs show decreased hunger and increased fullness ratings, though results in specific diabetic populations have been mixed.

Thylakoids—the chlorophyll-containing membrane structures from green leaves—have been tested in multiple human clinical trials and a systematic review for effects on appetite and satiety. A 2020 systematic review of 8 human RCTs found that thylakoid supplementation consistently increased postprandial cholecystokinin and leptin while reducing ghrelin, producing measurable reductions in hunger. A human study in overweight women found thylakoid supplementation with a high-carbohydrate meal decreased hunger and elevated CCK levels.

Clinical research suggests chromium may modestly suppress appetite and reduce food intake, particularly in individuals with carbohydrate cravings. A double-blind RCT found chromium picolinate reduced food intake, hunger, and fat cravings in overweight women. The proposed mechanism involves sensitization of brain glucoreceptors and effects on serotonin and dopamine pathways.

Multiple clinical trials indicate chromium picolinate can modestly reduce hunger, food intake, and carbohydrate cravings, particularly in overweight individuals who are carbohydrate cravers. A randomized double-blind, placebo-controlled study at the Pennington Biomedical Research Center found that chromium picolinate reduced hunger by 24% and food intake by 25% in overweight non-diabetic women over 8 weeks. Effects are moderate and appear most pronounced in those with carbohydrate cravings.

Citrus pectin, as a soluble dietary fiber, contributes to satiety and appetite regulation by increasing gastric viscosity, slowing gastric emptying, and promoting secretion of satiety hormones. Human intervention studies have examined pectin's effect on appetite and energy intake, though results depend on molecular weight and degree of esterification.

CLA has been studied for its effects on leptin, a key appetite-regulating hormone. Meta-analyses of RCTs show CLA supplementation significantly reduces circulating leptin levels, which may influence satiety signaling. Evidence for direct appetite suppression in humans is modest and indirect.

MCTs in coconut milk have been shown in controlled trials to reduce subsequent energy intake over 48 hours, likely via delayed gastric emptying and elevated ketone levels rather than classical appetite hormone modulation. A 2020 systematic review confirmed MCTs decrease energy intake compared to long-chain triglycerides, though effects on subjective appetite ratings are inconsistent.

Damiana has been studied as part of the YGD herbal combination (yerba maté, guarana, damiana) for appetite suppression. Human studies show the combination slows gastric emptying and reduces caloric intake. Isolating damiana's individual contribution remains difficult as all studies used multi-herb formulas.

The German Commission E and EMA have approved Devil's Claw for temporary loss of appetite, based on its bitter iridoid content. Bitters traditionally stimulate appetite via increased gastric secretion. Regulatory endorsement gives this application formal status beyond purely traditional use. Human trial data specific to appetite as a primary endpoint is limited.

EGCG, the primary catechin in green tea, delays gastric emptying in a double-blind RCT in healthy women, prolonging satiety. It also inhibits COMT, potentiating norepinephrine-mediated thermogenesis and appetite suppression. Effects on appetite are enhanced in combination with caffeine.

Whole eggs provide high-quality, complete protein that measurably suppresses hunger hormones and extends satiety. Multiple RCTs show egg-based breakfasts reduce postprandial appetite ratings and subsequent food intake compared to lower-protein or carbohydrate-matched breakfasts. Effects are mediated in part by modulation of ghrelin and satiety-related peptides.

Fava beans contain both protein and dietary fiber, two established satiety-promoting macronutrients. A randomized crossover trial in healthy men found that a fava bean/split pea meal produced appetite and energy-intake outcomes comparable to matched animal-protein meals. A separate clinical study found fava bean protein flour added to pasta reduced postprandial glycemia and appetite scores.

Fenugreek seeds contain high-viscosity soluble fiber (galactomannan) that swells in the stomach and slows gastric emptying, significantly reducing hunger and next-meal caloric intake in RCTs. A single-blind randomized crossover trial in 18 obese subjects found 4–8 g fenugreek fiber at breakfast significantly lowered hunger ratings and reduced subsequent caloric intake. Traditional Ayurvedic, Chinese, and Middle Eastern use for appetite and digestive regulation spans over 2,000 years.

Clinical trials have investigated flaxseed's effect on satiety and hunger with mixed but partly positive results. A systematic review of 13 RCTs found that results were inconsistent, though three studies showed a significant reduction in hunger and appetite. The high mucilage (soluble) fiber content is the primary proposed mechanism, forming a gel that slows gastric emptying.

FOS supplementation stimulates GLP-1 and PYY release via SCFA-GPR41/43 signaling, hormones that reduce hunger. Human ITF trials including scFOS have shown reduced energy intake and improved satiety ratings in some RCTs. However, effect sizes are modest and not consistently replicated across all populations.

The high fiber and protein content of garbanzo beans—approximately 12–15 g fiber and 14–15 g protein per cup cooked—promotes satiety via slowed gastric emptying, stimulation of cholecystokinin (CCK) release, and reduction in postprandial insulin spikes. A meta-analysis of 21 trials (American Journal of Clinical Nutrition, 2016) found that adding pulses including chickpeas to the diet led to modest weight loss even without intentional calorie restriction, consistent with improved satiety.

Garcinia cambogia extract contains hydroxycitric acid (HCA), which inhibits ATP-citrate lyase (reducing fatty acid synthesis) and may elevate serotonin, potentially suppressing appetite. Two of five RCTs in a systematic review found significant appetite reduction with HCA vs. placebo. However, higher-quality trials including a landmark JAMA RCT found no significant appetite or weight effects, making overall evidence mixed.

The EMA's Committee on Herbal Medicinal Products (HMPC) formally classified gentian root as a traditional herbal medicinal product for temporary loss of appetite, based on long-standing documented use. Germany's Commission E likewise approves an infusion of gentian root for appetite imbalance and mild digestive disorders. Bitter compounds in gentian activate taste receptors that reflexively stimulate salivary, gastric, and bile secretions, creating an appetite-priming effect. Typical dosing is 1 g dried root steeped in 150 mL water, taken 30 minutes before meals, up to 2–4 g daily.

Gentian root's bitter secoiridoids (gentiopicroside, amarogentin) activate oral and gastrointestinal bitter taste receptors (TAS2Rs), reflexively increasing saliva and gastric acid secretion to stimulate appetite. A small human RCT in 50 children with anorexia showed significantly increased appetite, body weight, and caloric intake after two months of daily gentian extract versus placebo. German Commission E, ESCOP, and the EMA HMPC all formally approve gentian root as a bitter remedy for loss of appetite. Typical dosing is 1–4 g dried root daily as a tea, or an equivalent tincture, consumed 30 minutes before meals.

Ginger has been studied for its potential to modulate appetite and support weight management. A 2018 systematic review identified potential mechanisms including thermogenesis, lipolysis, suppression of lipogenesis, and appetite control. Human clinical evidence is limited and results are inconsistent, with only slight changes in anthropometric measurements observed in most trials.

Glucomannan is a highly viscous soluble fiber from konjac that forms a large gel in the stomach, slowing gastric emptying and promoting satiety. Multiple RCTs and a systematic review confirm its appetite-suppressing and satiety-enhancing properties. EFSA has recognized glucomannan's contribution to weight management when taken before meals with water.

Clinical trials suggest grapefruit may reduce appetite and promote satiety when consumed before meals, partly through its fiber content and low energy density. A 12-week Scripps Clinic RCT found that participants eating grapefruit lost weight and showed reduced insulin levels without other dietary changes. Pre-meal grapefruit preloads have been studied as a low-energy-density satiety strategy in obese adults.

Green tea contains both EGCG and caffeine, which together suppress appetite, reduce ghrelin, and support modest weight loss. A 12-week RCT in women with abdominal obesity found green tea supplementation reduced weight (~2.5 lbs), lowered cholesterol, and decreased ghrelin. EGCG alone delays gastric emptying in a double-blind RCT, contributing to prolonged satiety.

Griffonia simplicifolia seeds contain 5–10% 5-HTP by dry weight and are the primary commercial source of 5-HTP used in multiple double-blind RCTs demonstrating appetite reduction and weight loss. All key 5-HTP appetite clinical trials used Griffonia-derived 5-HTP. Examine.com rates the appetite evidence for 5-HTP as Grade A from 8 trials and 711 participants.

Guarana seeds contain 2–8% caffeine (guaranine), theobromine, and saponins that suppress appetite and enhance thermogenesis. The combination of guarana, yerba mate, and damiana clinically slowed gastric emptying by 15–58% and induced significant weight loss over 45 days. Traditional use by Amazonian peoples as a hunger suppressant during food scarcity is well documented.

Gymnema contains gymnemic acids that block sweet taste receptors, eliminating sweet taste perception for up to 90 minutes and reducing appetite for sweet foods. Traditional Ayurvedic medicine has used it for over 2,000 years as gurmar. A double-blind RCT found 400 mg/day reduced appetite and food intake in overweight participants.

Gymnema sylvestre contains gymnemic acids that competitively block sweet taste receptors (T1R2/T1R3), suppressing sweet taste perception for up to 90 minutes and reducing cravings for sweet foods. A double-blind RCT found 400 mg/day reduced appetite and food intake in overweight participants. Traditional Ayurvedic use as gurmar for over 2,000 years supports its reputation as a sugar-craving suppressant.

Bitter compounds in hops—alpha- and beta-acids—are ligands for human bitter taste receptors and stimulate cholecystokinin (CCK) and other gut peptide hormone release, which modulates satiety signaling. A human crossover RCT of a supercritical CO₂ hops extract showed acute reduction in energy intake and modulation of appetite hormones.

HCA inhibits ATP-citrate lyase, redirecting citrate toward hepatic glycogen synthesis, which signals satiety. In isolated rat brain cortex, HCA increases serotonin availability, a neurotransmitter linked to eating behavior. Human RCTs have produced mixed results, with some showing reduced food intake and others showing no significant effect on appetite versus placebo.

Multiple RCTs show inulin-type fructans (ITF) reduce subjective hunger ratings, desire to eat, and prospective food consumption. The mechanism involves colonic fermentation producing short-chain fatty acids (SCFAs) that stimulate GLP-1 and PYY release from intestinal L-cells, suppressing appetite signals. Effects appear more consistent on subjective ratings than on actual energy intake reduction.

IMO fiber may suppress appetite by increasing gastric volume and promoting release of satiety hormones including GLP-1 and CCK. Animal studies show modulation of hypothalamic appetite-regulating genes. Human evidence is indirect and based on subjective appetite ratings in bar/food matrix studies.

Kelp's soluble fiber alginate has been studied in human trials for satiety and appetite reduction. Alginate forms a viscous gel in the gut that slows gastric emptying and fat absorption. A study published in Appetite found that alginate supplementation led to consumption of approximately 135 fewer calories over 24 hours. Evidence is preliminary but based on human data.

Kidney beans, via their high fiber and protein content and the starch-blocking activity of phaseolamin, enhance satiety and reduce appetite. Clinical reviews link WKBE supplementation to diminished food intake and improved portion control in overweight individuals.

Konjac is the plant source of glucomannan, a viscous soluble fiber that forms a bulky gel in the stomach, reducing subsequent caloric intake by 23–47% in crossover trials. EFSA recognizes konjac glucomannan for weight management. Traditional use in East Asian cuisines as a satiety food predates modern research.

L-histidine suppresses food intake by raising brain histamine, which acts via H1 receptors in the ventromedial and paraventricular hypothalamic nuclei to inhibit feeding and promote lipolysis. Human observational data link higher dietary histidine to lower BMI and waist circumference in obese individuals. However, one double-blind trial failed to show appetite suppression from oral L-histidine, reflecting mixed human evidence.

Leucine acts as a nutrient-sensing signal in the hypothalamus, activating mTORC1 and suppressing appetite-driving neuropeptides. Human data show leucine-rich protein sources increase satiety, and leucine supplementation alone is sufficient to produce satiety in healthy humans. Central administration models further confirm dose-dependent food intake reduction via POMC and NPY neurocircuits.

L-phenylalanine suppresses food intake in rodents and humans via gut hormone stimulation, including CCK and PYY. A human randomized crossover study showed intragastric L-Phe (5 g and 10 g) reduced energy intake from a subsequent buffet meal. The effect is dose-dependent and mediated primarily by CCK and PYY rather than GLP-1 slowing of gastric emptying in humans.

L-Tryptophan stimulates release of the satiety hormone cholecystokinin (CCK) and slows gastric emptying in human trials. At doses of 1.5–3 g administered intragastrically, it has been shown to suppress energy intake in both lean individuals and those with obesity. Effects on subjective hunger ratings are less consistent across studies.

Macadamia nuts promote satiety through their high content of MUFAs, fiber, and protein, which slow digestion and modulate hunger hormones. Clinical evidence from nut trials including macadamia shows improved satiety scores versus refined carbohydrate comparators. Their palmitoleic acid (omega-7) content is specifically linked to reduced appetite signaling.

A 2020 systematic review and meta-analysis (17 studies, 291 participants) found that MCT supplementation produced a statistically significant moderate reduction in ad libitum energy intake compared to long-chain triglycerides (LCT), though effects on subjective appetite ratings and hunger hormones were minimal. The calorie-reducing effect appears to operate through mechanisms other than classic appetite-hormone suppression. Evidence is consistent but effect sizes are modest.

Mulberry leaf extract's inhibition of α-glucosidase reduces postprandial glucose and insulin surges, which are major drivers of subsequent hunger and appetite. By flattening the glycaemic curve, mulberry extract may reduce reactive hypoglycaemia-triggered appetite. This mechanism is supported by human RCT data showing significant reductions in postprandial insulin.

Nopal fiber's high soluble and insoluble fiber content promotes satiety and slows gastric emptying, which is biologically plausible for appetite suppression. A double-blind placebo-controlled crossover trial (N=64) showed nopal extract pretreatment significantly reduced anorexia (a surrogate for appetite dysregulation) associated with alcohol hangover. Human weight management trials have included appetite reduction as a proposed mechanism, and EBSCO documents human studies on appetite control.

Oat β-glucan increases feelings of fullness and satiety through viscosity-mediated slowing of gastric emptying and modulation of appetite hormones including ghrelin reduction. RCT evidence supports subjective appetite suppression, though effects on actual energy intake are less consistent.

Oleic acid is the dietary precursor to oleoylethanolamide (OEA), an endogenous lipid mediator produced in the small intestinal wall after fat ingestion. OEA activates PPAR-α receptors and vagal sensory fibers to signal satiety to the brainstem and hypothalamus. Early human evidence and a 2025 systematic review and meta-analysis of RCTs indicate OEA supplementation is associated with reduced hunger and modest weight loss in overweight individuals.

Oleic acid in olive oil is metabolically converted to oleoylethanolamide (OEA) in the gut, which activates PPARα receptors to signal satiety to the hypothalamus. Clinical studies show EVOO-rich diets reduce post-meal hunger ratings compared to diets high in saturated fat. These mechanisms contribute to olive oil's role in sustainable appetite regulation.

A double-blind RCT in adults with impaired glucose tolerance found that a meal fortified with oyster mushroom powder reduced hunger-AUC by 22% versus control. The mechanism involves β-glucan-mediated GLP-1 elevation and delayed gastric emptying. The 2020 systematic review noted that appetite was not formally assessed in earlier P. ostreatus trials.

Multiple human clinical trials demonstrate that pea protein consumed as a preload increases satiety and reduces subsequent food intake for up to 120 minutes post-ingestion. Pea protein stimulates release of satiety hormones CCK, GLP-1, and PYY. Effects are comparable to whey protein in acute studies.

Clinical trials show peanuts and peanut butter increase satiety hormones (GLP-1, PYY, CCK) and reduce desire to eat. A randomised crossover trial in obese women found peanut butter consumption lowered postprandial glucose and enhanced gut satiety hormone secretion. Pre-meal peanut intake has been shown to moderate appetite in energy-restricted weight loss diets.

Pectin, as a viscous soluble fiber, slows gastric emptying and promotes satiety signaling. Animal studies show dietary pectin substantially raises PYY and total GLP-1. Human evidence supports subjective reduction in hunger after pectin-enriched meals, though effect sizes in controlled trials are modest.

Psyllium (Plantago ovata) demonstrably reduces appetite and hunger through its viscous gel, which slows gastric emptying and stimulates satiety hormones. Multiple clinical trials report reduced hunger and energy intake with psyllium supplementation before or with meals.

An Opuntia ficus-indica fiber complex (Litramine) at 3 g/day significantly reduced body weight, BMI, and body fat in a 12-week double-blind RCT in 125 overweight adults, with fat-binding as the primary mechanism. The fiber also promotes satiety by slowing gastric emptying.

Propionate stimulates the release of gut hormones PYY and GLP-1 from colonic L cells, which signal satiety to the brain and suppress food intake. A randomized controlled trial in 60 overweight adults using an inulin-propionate ester demonstrated that acute ingestion significantly increased postprandial PYY and GLP-1 and reduced energy intake. The mechanism operates primarily through free fatty acid receptors FFAR2 and FFAR3 expressed on enteroendocrine cells.

Psyllium husk is a viscous soluble fiber that forms a large gel in the GI tract, slowing gastric emptying and promoting satiety by stimulating GLP-1 and PYY release. A systematic review and meta-analysis of RCTs confirmed viscous soluble fibers including psyllium significantly increase perceived satiety and reduce energy intake. Traditional Ayurvedic use as Isabgol for digestive regulation and satiety spans centuries.

Quinoa's combination of complete protein (~8 g/cup) and dietary fiber (~5 g/cup) promotes satiety and reduces subsequent food intake. A pre-diabetic RCT found increased satiation with quinoa consumption. Protein and fiber are established regulators of appetite hormones (leptin, ghrelin, GLP-1), and quinoa's low GI prevents blood sugar crashes that trigger hunger.

Relora® has been clinically studied for appetite and satiety, particularly in stress-related eating contexts. The magnolia and phellodendron fractions may bind to GABA receptors and serotonin transporters in the CNS, which are associated with feelings of satiety. A follow-up pilot RCT showed Relora may help diminish stress-related sugary snack cravings and promote healthier eating habits. Effects appear primarily mediated through stress and cortisol reduction rather than direct appetite suppression.

Multiple randomized controlled trials demonstrate that whole-grain rye products increase subjective satiety and reduce hunger compared with refined wheat. The effect is attributed to rye's dense structure, high dietary fiber, and fermentation-driven gut hormone responses. A 2015 systematic review confirmed that rye is among the grains with the strongest evidence for satiety enhancement.

Saffron and its constituent crocin significantly reduce appetite, snacking, and dietary intake in multiple RCTs. An 8-week double-blind RCT in 84 CAD patients found both saffron aqueous extract and crocin significantly decreased appetite and energy intake vs. placebo. Mechanism involves serotonin reuptake inhibition modulating satiety signaling.

Shen-chu (as Shenqu Xiaoshi Oral Solution) has demonstrated clinical efficacy in treating infantile anorexia (IFA). Animal studies using juvenile rat models have validated its pharmacodynamic mechanism in restoring appetite and digestive function. It is also traditionally noted to relieve poor appetite arising from food stagnation.

Sphaeranthus indicus flower head extract, particularly in the Meratrim formulation combined with Garcinia mangostana, demonstrated significant reductions in body weight, waist circumference, and appetite-related outcomes in a double-blind RCT and was identified in a 2019 systematic review as providing longer-term evidence for appetite suppression among herbal medicine trials. Traditional Ayurvedic use for digestive and metabolic management is well documented.

Thylakoids extracted from spinach chloroplasts slow fat digestion in the gut, promoting the release of satiety hormones including CCK and GLP-1. Multiple RCTs in overweight women show significant reductions in hunger ratings and cravings for palatable foods. Effects include reduced calorie intake and lower ghrelin levels.

Multiple RCTs and a systematic meta-analysis report that spirulina supplementation significantly reduces appetite scores and food intake in overweight or obese individuals. A double-blind, placebo-controlled study in 52 obese adults found that 12 weeks of spirulina supplementation significantly reduced food intake and body weight compared with placebo. The mechanism proposed involves increased GLP-1 release, which induces satiety, as well as phenylalanine-mediated cholecystokinin release.

Small human crossover trials suggest stevia preloads reduce subjective hunger and desire to eat compared to water. A 12-week RCT in healthy adults found that the stevia group significantly reduced energy intake over time and maintained body weight, while the control group gained weight. Evidence for meaningful caloric compensation suppression is modest and context-dependent.

Human RCT data indicate that stevia-sweetened preloads do not cause compensatory caloric intake increases compared to sucrose, and stevia use in place of sugar reduces post-meal glycemia and insulinemia. A 2025 systematic review and meta-analysis specifically assessed stevia's effect on appetite in adults from RCTs.

Synephrine (p-synephrine from bitter orange, Citrus aurantium) selectively activates beta-3 adrenergic receptors, stimulating lipolysis and suppressing appetite. A placebo-controlled RCT found that 103 mg/day p-synephrine for 15–30 days produced statistically significant reductions in appetite vs. placebo with no adverse cardiovascular effects. Over 30 human clinical studies with 700+ subjects have assessed its safety and efficacy.

A 2026 peer-reviewed study in Experimental & Molecular Medicine (Nature Publishing Group) demonstrated that threonic acid itself suppresses appetite in diet-induced obese mice by reversing fasting-induced upregulation of the hypothalamic orexigenic neuropeptides NPY and AgRP. This is the first direct evidence for a metabolic/appetite role of free threonic acid.

Whey protein is among the most satiating dietary proteins, stimulating GLP-1, CCK, and PYY while suppressing ghrelin. Multiple RCTs confirm that pre-meal whey protein significantly reduces subsequent appetite and caloric intake. A 2025 RCT found pre-meal whey protein microgel reduced postprandial appetite and ad-libitum food consumption in overweight adults.

Yarrow is approved by the German Commission E and ESCOP for loss of appetite and dyspeptic complaints. Its bitter constituents and flavonoids act as digestive stimulants, encouraging bile flow and gastric tone. This official recognition is backed by documented pharmacological activity.

Yerba mate contains caffeine, theobromine, and chlorogenic acids that suppress appetite, delay gastric emptying, and support weight management. A double-blind placebo-controlled RCT found 3 g/day yerba mate for 12 weeks reduced body fat. The combination of yerba mate, guarana, and damiana slowed gastric emptying by 15–58% and induced significant weight loss without dietary changes in clinical trials.

Ajwain is traditionally classified as an appetizer ('deepan') in Ayurveda and Unani medicine, used to stimulate appetite and treat anorexia. Its pungent aroma and bitter taste are thought to trigger salivary and gastric secretions. No controlled human trials have assessed its appetite-stimulating effects.

Allspice has a documented traditional use for stimulating appetite and relieving dyspepsia. Its carminative and digestive-stimulant properties are attributed to eugenol and volatile oils. No human clinical trials have evaluated it specifically for appetite regulation.

Artichoke has a long traditional use as a bitter herb that stimulates appetite via its bitter sesquiterpene lactones (cynaropicrin) acting on digestive secretions. The German Commission E and ESCOP monographs reference appetite stimulation through bitterness-induced digestive enzyme and bile secretion. Clinical evidence is indirect—from dyspepsia and digestive studies—rather than from dedicated appetite trials.

Banaba has been used in Philippine folk medicine to support weight management, with traditional use framing blood-sugar stabilization as a mechanism for reducing food cravings. Animal studies show anti-adipogenic and anti-obesity effects, and banaba has been incorporated into multi-ingredient weight-management formulas. Direct human evidence isolating banaba's effect on appetite specifically is lacking.

Barberry has traditional use for appetite regulation, listed as a remedy for loss of appetite in herbal medicine references. It was used as a bitter tonic to stimulate appetite. No clinical trial data specifically for appetite control are available.

Blessed thistle has been approved by Germany's Commission E for loss of appetite, based on its well-documented traditional use as a bitter tonic. The sesquiterpene lactone cnicin stimulates salivary and gastric secretions through a reflex mechanism common to bitter herbs. No controlled human clinical trials have confirmed this effect specifically for blessed thistle.

Caraway has centuries of traditional use as an appetizer and digestive stimulant across European, Persian, and Ayurvedic systems. Traditional scholars recorded it as an appetite promoter. Modern clinical trials on caraway for obesity showed weight reduction, but whether this reflects appetite suppression or other metabolic mechanisms is not established.

In TCM, Chen Pi is traditionally prescribed to stimulate appetite (treat 'inappetence') by strengthening Spleen Qi and increasing gastric secretions. Its aromatic volatile oils are understood to awaken digestive function and reduce food stagnation.

Cumin is traditionally used as an appetite stimulant in Ayurvedic and Middle Eastern medicine, and its bitter taste compounds were historically recognized as appetite-awakening. Modern clinical evidence for cumin specifically as an appetite modifier is absent.

Dandelion is formally recognized by Health Canada (citing EMA, ESCOP, and WHO monographs), the German Commission E, and ESCOP as a traditional herbal medicine for stimulating appetite. The bitter principles in the root and leaf activate digestive secretion reflexes. No human RCTs specifically for appetite endpoints exist.

American dogwood (Cornus florida) has documented traditional use for stimulating appetite and as a tonic for general debility, listed by RxList and WebMD. The bitter compounds in the bark are a plausible mechanism for digestive and appetite stimulation. No clinical evidence exists.

Elecampane root has a long history of use as a bitter digestive tonic, with the bitter constituents traditionally credited with stimulating appetite and digestive secretions. This use is documented across Western, Ayurvedic, and TCM traditions. No controlled clinical trials have evaluated this effect specifically.

E. littorale is traditionally described as a tonic for appetite loss and as a stomachic bitter in Ayurveda and Indian folk medicine. Its bitter taste quality (Tikta rasa) is the classical pharmacological basis for this use in the Ayurvedic system. No controlled clinical evidence for appetite modulation is available.

Fennel has a long traditional use as an appetite suppressant and digestive tonic across Mediterranean and South Asian cultures. Chewing fennel seeds after meals is a widespread practice to curb hunger and support satiety. Direct human clinical evidence specifically for appetite suppression remains limited.

Green chiretta is traditionally used as a bitter tonic to stimulate appetite in Ayurveda and TCM. Its intensely bitter taste triggers digestive secretions and gastric juices that increase appetite. It has also been used to restore appetite after illness.

Hoodia gordonii has been used by the San (Bushmen) people of southern Africa for centuries to suppress appetite and thirst during long hunting expeditions. Its proposed active compound P57 is thought to mimic glucose signaling in hypothalamic neurons to reduce hunger. Rigorous human clinical trial evidence is very limited; the best-designed RCT did not demonstrate significant appetite reduction and raised safety concerns.

Horehound's bitter compounds, particularly marrubiin, are recognized by the German Commission E and the EMA's HMPC as stimulating gastric juice secretion and appetite via activation of bitter taste receptors. This traditional use has at least 30 years of documented safe use in Europe. No controlled human trials specifically measuring appetite endpoints have been conducted.

TCM prescribes Lablab Semen Album for loss of appetite associated with spleen-stomach weakness, a well-codified indication in Chinese pharmacopeias. This represents a traditional rather than clinically validated use.

Kanna was traditionally used by San and Khoikhoi peoples as a hunger and thirst suppressant during hunting trips. This use is documented in multiple peer-reviewed ethnobotanical reviews and pharmaceutical monographs. Preclinical receptor data suggests cholecystokinin receptor activation (a satiety signaling mechanism). No human clinical trials have assessed appetite suppression.

Momordica charantia is listed as an 'appetite stimulant' in traditional medicine documentation, particularly in African ethnomedicine. The bitter taste may stimulate digestive secretions and appetite. No human clinical evidence for appetite modulation exists.

Mugwort has been recorded as a bitter digestive tonic and appetizer across traditional European and Asian herbal systems. The bitter sesquiterpene lactones in the plant stimulate gastric secretion, which is the classical mechanism of herbal appetite stimulants. No human clinical trials support this use.

Mustard seeds stimulate appetite and gastric secretion via their pungent volatile oils—a traditional bitter tonic use—while also having anecdotal reports of appetite suppression through sensory pungency. The two opposing uses (appetite stimulant vs. suppressant) reflect different doses and preparations. Dedicated human appetite studies are lacking.

Orange peel has traditional use as an appetite stimulant and digestive tonic across European and Asian herbal medicine, particularly using bitter compounds to stimulate gastric secretion. Sweet orange peel was used in traditional remedies to support healthy appetite. Some evidence exists that orange fibre (pectin) promotes satiety, but clinical RCT evidence for appetite control is limited.

Oregon grape berries and root decoction were specifically used by Native American tribes for poor appetite and debility. The root bark was historically given as a bitter tonic to stimulate appetite and digestion. No clinical trials have evaluated Oregon grape for appetite regulation.

The galls of Pistacia integerrima have long been used as an appetizer in Ayurvedic and Unani medicine. Traditional practitioners of the Subcontinent describe the galls as aromatic and astringent with properties that stimulate appetite. No controlled human trials on appetite effects have been published.

Radish root has documented traditional use for loss of appetite (anorexia), listed by RxList as one of its recognized folk medicine indications. The stimulation of bile flow and digestive juices is the proposed mechanism. No human clinical trials have evaluated this effect.

San and Khoikhoi hunter-gatherers traditionally used sceletium to suppress hunger and thirst during long hunts. This is recorded across multiple ethnobotanical sources and peer-reviewed ethnopharmacology reviews. No clinical trial has formally evaluated appetite suppression.

The Pharmacopoeia of China describes Z. bungeanum as beneficial for persons who have lost appetite, reflecting its TCM role as an appetitive tonic. Its carminative and gastric-secretion-stimulating properties provide mechanistic support, but no appetite-specific human trials exist.

A. calamus is traditionally used as an appetite stimulant in Ayurveda, Unani, and multiple folk medicine traditions, listed explicitly for 'appetite loss' among its indications. Its bitter aromatic constituents mechanistically support digestive and appetite stimulation. No human appetite trials exist.

Swertia chirayita is classically described as a bitter tonic and appetizer in Ayurveda, Unani, and Siddha systems. The intensely bitter compound amarogentin is held to stimulate appetite and digestive secretions. This use is documented in the Indian Pharmaceutical Codex and British Pharmacopoeia. No controlled human trials specifically on appetite stimulation have been published.

T. cordifolia is traditionally used for loss of appetite and digestive debility (Deepana effect). PMC 3885194 lists it as used for 'loss of appetite and fever in children' in Ayurvedic texts. Its bitter digestive (Deepana-Pachana) properties are foundational to its role in appetite stimulation.

Appetite stimulation is documented as a traditional use of Triphala in Ayurvedic practice and is noted in scientific reviews of its pharmacology. Animal data suggest Triphala may restore serotonin and dopamine levels relevant to appetite regulation. Clinical human data specifically for appetite control are limited.

Yellow Root has been used as a bitter tonic by Cherokee and Appalachian herbalists to stimulate appetite and digestive secretions. As a bitter herb, it fits the classic phytotherapeutic model of bitter-stimulated appetite enhancement. No clinical trials on Yellow Root itself have assessed this effect.